Skip to content

LifeMD, Inc. LFMD EBITDA margin

EBITDA margin at other companies

CVS Health logo
CVS HealthCVS
2.6%-1.2pp
Spok Holdings logo
Spok HoldingsSPOK
14.4%-2.9pp
Teladoc Health logo
Teladoc HealthTDOC
6.1%+3.3pp
Hims & Hers Health logo
Hims & Hers HealthHIMS
1.6%-5.8pp
LifeStance Health Group logo
LifeStance Health GroupLFST
6.6%+2.9pp
DocGo logo
DocGoDCGO
-55.7%

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Calculated from LifeMD, Inc.’s reported figures.

Based on trailing twelve months.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s EBITDA margin?
LifeMD, Inc. (LFMD) reported EBITDA margin of -8.9% in Q1 2026.
How has LifeMD, Inc.'s EBITDA margin changed year-over-year?
LifeMD, Inc.'s EBITDA margin increased by 13.1% year-over-year, from -10.2% to -8.9%.
What is the long-term trend for LifeMD, Inc.'s EBITDA margin?
Over 5 years (2020 to 2025), LifeMD, Inc.'s EBITDA margin has grown at a -50.3% compound annual growth rate (CAGR), from -154.1% to -4.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.